Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.25p
   
  • Change Today:
    -0.100p
  • 52 Week High: 6.25
  • 52 Week Low: 0.88
  • Currency: UK Pounds
  • Shares Issued: 4,766.44m
  • Volume: 591,351
  • Market Cap: £154.91m
  • RiskGrade: 268

Regulatory News

PDMR dealing and Total Voting Rights 13-Dec-2023 16:54 RNS
G306 Phase III trial meets key endpoints 13-Dec-2023 07:00 RNS
Update on funding 11-Dec-2023 07:00 RNS
Total Voting Rights 01-Dec-2023 07:00 RNS
Holding(s) in Company 28-Nov-2023 15:03 RNS
G306 Grass Phase III trial meets primary endpoint 14-Nov-2023 07:00 RNS
Form 8.5 (EPT/RI) 10-Nov-2023 14:39 RNS
Director/PCA Dealing 10-Nov-2023 13:22 RNS
Holding(s) in Company 10-Nov-2023 13:11 RNS
Offer Closure 10-Nov-2023 07:00 RNS
Exercise of Options and Total Voting Rights 09-Nov-2023 10:48 RNS
Form 8.5 (EPT/RI) 09-Nov-2023 09:24 RNS
Form 8.5 (EPT/NON-RI) 09-Nov-2023 09:15 RNS
Form 8.5 (EPT/RI) 08-Nov-2023 10:45 RNS
Form 8.5 (EPT/RI) 07-Nov-2023 11:10 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AGY Market Data

Currency UK Pounds
Share Price 3.25p
Change Today -0.100p
% Change -2.99 %
52 Week High 6.25
52 Week Low 0.88
Volume 591,351
Shares Issued 4,766.44m
Market Cap £154.91m
RiskGrade 268

AGY Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
18.39% below the market average18.39% below the market average18.39% below the market average18.39% below the market average18.39% below the market average
17.65% above the sector average17.65% above the sector average17.65% above the sector average17.65% above the sector average17.65% above the sector average
Price Trend
32.48% below the market average32.48% below the market average32.48% below the market average32.48% below the market average32.48% below the market average
3.7% below the sector average3.7% below the sector average3.7% below the sector average3.7% below the sector average3.7% below the sector average
Income Not Available
Growth
84.14% below the market average84.14% below the market average84.14% below the market average84.14% below the market average84.14% below the market average
82.35% below the sector average82.35% below the sector average82.35% below the sector average82.35% below the sector average82.35% below the sector average

AGY Dividends

No dividends found

Trades for 17-May-2024

Time Volume / Share Price
16:26 34,261 @ 3.21p
15:58 29,969 @ 3.31p
14:00 5,000 @ 3.25p
14:00 5,000 @ 3.25p
13:04 49,000 @ 3.40p

AGY Key Personnel

CEO Manuel Llobet

Top of Page